Baxter International BAX
NYSE BAX
$26.34 -0.07 (-0.27%)
At close: Aug 21, 2026 · 4:00 PM EDT

Baxter International (BAX) Cash from Investing Activities (2009 - 2026)

Baxter International (BAX) posted quarterly Cash from Investing Activities of -$117.0 million for Q2 2026, down 1.74% year-over-year from -$119.1 million in Q2 2025, and up 12.03% quarter-over-quarter from -$133.0 million in Q1 2026.

Baxter International (BAX) Cash from Investing Activities (2009 - 2026) Analysis & Trends

Baxter International (BAX) has reported Cash from Investing Activities for 18 consecutive years, with -$117.0 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Cash from Investing Activities fell 1.74% year-over-year to -$117.0 million; the TTM figure through Jun 2026 stood at -$559.0 million (down 120.1% YoY), while the FY2025 annual figure was $2.8 billion, up 553.83% from the prior year.
  • Cash from Investing Activities improved to -$117.0 million in Q2 2026 per BAX's latest filing, from -$133.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $3.8 billion in Q3 2023 and bottomed at -$304.0 million in Q1 2022.
  • Historically, Cash from Investing Activities has averaged $235.9 million across 5 years, with a median of -$168.0 million in 2023.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 2157.61% — and 2024, when it plunged 104.33%.
  • Baxter International's Cash from Investing Activities stood at -$256.0 million in 2022, then climbed by 10.16% to -$230.0 million in 2023, then gained by 10.87% to -$205.0 million in 2024, then grew by 3.41% to -$198.0 million in 2025, then soared by 40.91% to -$117.0 million in 2026.
  • Business Quant data shows BAX's Cash from Investing Activities at -$117.0 million in Q2 2026, -$133.0 million in Q1 2026, and -$198.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -26.60 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -241.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -222.00 Mn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -383.65 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -461.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -43.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -87.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -90.00 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -117.00 Mn
10 Align Technology 11.61 Bn 10.51 Bn 757.43 Mn -82.16 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -117.00 Mn
Jun 30, 2026 -117.00 Mn
Mar 31, 2026 -133.00 Mn
Mar 31, 2026 -133.00 Mn
Dec 31, 2025 -3.50 Bn
Dec 31, 2025 -3.50 Bn
Sep 30, 2025 3.28 Bn
Sep 30, 2025 3.28 Bn
Jun 30, 2025 -3.50 Bn
Jun 30, 2025 -3.50 Bn
Mar 31, 2025 3.27 Bn
Mar 31, 2025 3.27 Bn
Dec 31, 2024 -205.00 Mn
Dec 31, 2024 -205.00 Mn
Sep 30, 2024 -164.00 Mn
Sep 30, 2024 -164.00 Mn
Jun 30, 2024 -157.00 Mn
Jun 30, 2024 -157.00 Mn
Mar 31, 2024 -100.00 Mn
Mar 31, 2024 -100.00 Mn